GL Sciences Inc.
GL Sciences Inc. Fundamental Analysis
GL Sciences Inc. (7705.T) shows moderate financial fundamentals with a PE ratio of 8.25, profit margin of 9.24%, and ROE of 10.80%. The company generates $37.1B in annual revenue with N/A year-over-year growth of N/A.
Key Strengths
Areas of Concern
The stock receives a Fundamental Health Score of 75.8/100 based on profitability, valuation, growth, and balance sheet metrics. The B grade reflects solid fundamentals with room for improvement in valuation or growth.
Fundamental Health Score
We analyze 7705.T's fundamental strength across five key dimensions:
Efficiency Score
Weak7705.T struggles to generate sufficient returns from assets.
Valuation Score
Excellent7705.T trades at attractive valuation levels.
Growth Score
Moderate7705.T shows steady but slowing expansion.
Financial Health Score
Excellent7705.T maintains a strong and stable balance sheet.
Profitability Score
Weak7705.T struggles to sustain strong margins.
Key Financial Metrics
Is 7705.T Expensive or Cheap?
P/E Ratio
7705.T trades at 8.25 times earnings. This suggests potential undervaluation.
PEG Ratio
When adjusting for growth, 7705.T's PEG of 0.08 indicates potential undervaluation.
Price to Book
The market values GL Sciences Inc. at 0.84 times its book value. This may indicate undervaluation.
EV/EBITDA
Enterprise value stands at 3.52 times EBITDA. This is generally considered low.
How Well Does 7705.T Make Money?
Net Profit Margin
For every $100 in sales, GL Sciences Inc. keeps $9.24 as profit after all expenses.
Operating Margin
Core operations generate 15.38 in profit for every $100 in revenue, before interest and taxes.
ROE
Management delivers $10.80 in profit for every $100 of shareholder equity.
ROA
GL Sciences Inc. generates $6.17 in profit for every $100 in assets, demonstrating efficient asset deployment.
Following the Money - Real Cash Generation
Operating Cash Flow
GL Sciences Inc. generates limited operating cash flow of $3.53B, signaling weaker underlying cash strength.
Free Cash Flow
GL Sciences Inc. produces free cash flow of $1.89B, offering steady but limited capital for shareholder returns and expansion.
FCF Per Share
Each share generates $184.39 in free cash annually.
FCF Yield
7705.T converts 6.68% of its market value into free cash.
Financial Ratios Analysis
Valuation Ratios
P/E Ratio
Price to earnings ratio
8.25
vs 25 benchmark
PEG Ratio
Price/earnings to growth ratio
0.08
vs 25 benchmark
P/B Ratio
Price to book value ratio
0.84
vs 25 benchmark
P/S Ratio
Price to sales ratio
0.76
vs 25 benchmark
Financial Health
Debt/Equity
Total debt to shareholders' equity
0.21
vs 25 benchmark
Current Ratio
Current assets to current liabilities
3.14
vs 25 benchmark
Efficiency Ratios
ROE
Return on equity percentage
0.11
vs 25 benchmark
ROA
Return on assets percentage
0.06
vs 25 benchmark
ROCE
Return on capital employed
0.13
vs 25 benchmark
How 7705.T Stacks Against Its Sector Peers
| Metric | 7705.T Value | Sector Average | Performance |
|---|---|---|---|
| P/E Ratio | 8.25 | 34.43 | Better (Cheaper) |
| ROE | 10.80% | 1135.00% | Weak |
| Net Margin | 9.24% | -134663.00% (disorted) | Weak |
| Debt/Equity | 0.21 | 7.92 | Strong (Low Leverage) |
| Current Ratio | 3.14 | 5.77 | Strong Liquidity |
| ROA | 6.17% | -310462.00% (disorted) | Weak |
7705.T outperforms its industry in 3 out of 6 key metrics, but lagging in ROE.
Historical Growth Performance
5-Year Growth Trajectory
This section reviews GL Sciences Inc.'s 5-year compound annual growth rate (CAGR) and compares its performance against the typical investment style of its industry.
Revenue CAGR
N/A
Industry Style: Growth, Innovation, High Beta
EPS CAGR
N/A
Industry Style: Growth, Innovation, High Beta
FCF CAGR
N/A
Industry Style: Growth, Innovation, High Beta